Study
Citicoline Supplementation Boosts Memory in Older Adults
Taking 500 mg of citicoline daily for 12 weeks improved memory in seniors with age-related memory issues.
Summary
In plain language
A recent study found that taking a daily supplement of citicoline, a naturally occurring compound, can help improve memory in seniors experiencing age-related memory decline. Over a 12-week period, healthy men and women aged 50 to 85 who took 500 mg of citicoline daily showed notable improvements in memory tests compared to those who took a placebo. This suggests that citicoline could be a helpful addition to the diet for older adults looking to maintain their cognitive health. If memory concerns are on your mind, discussing citicoline with your healthcare provider might be worthwhile.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was a well-designed clinical trial that included 100 healthy older adults aged 50 to 85. Participants were randomly assigned to receive either a citicoline supplement or a placebo for 12 weeks. Memory tests conducted before and after the study showed that those taking citicoline had significant improvements in memory, particularly in episodic memory.
The study was carefully controlled, with neither participants nor researchers knowing who received the supplement or placebo.
Citicoline improved memory scores significantly more than the placebo, with a notable increase in episodic memory performance.
While the study shows promise, it is important to remember that supplements can affect individuals differently.
Considering adding citicoline to your routine? It's a good idea to have a conversation with your healthcare provider first.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Citicoline Supplementation Boosts Memory in Older Adults
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 6, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly in study design and bias control due to its rigorous RCT methodology, including randomization and blinding. Statistical integrity was strong with pre-specified endpoints and appropriate analyses. Transparency was ensured through pre-registration and comprehensive reporting. However, conflicts of interest were present due to industry funding and employee involvement, and no replication was cited. The study was directly relevant to the target population, but journal quality could not be assessed.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This randomized, double-blind, placebo-controlled trial investigated the effects of citicoline supplementation on memory in healthy older adults with age-associated memory impairment. The study found significant improvements in episodic and composite memory scores in the citicoline group compared to placebo.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that affects memory, thinking, and behavior. It primarily impacts older adults, with symptoms gradually worsening over time. As the most common cause of dementia, Alzheimer's can lead to a significant decline in daily functioning and independence.
Hearing Loss (Age-Related)
Age-related hearing loss, also known as presbycusis, is a common condition that affects many older adults. It occurs gradually over time, often leading to difficulty hearing high-frequency sounds. This can impact communication, social interactions, and overall quality of life.
Macular Degeneration and Age-Related Vision Loss
Macular degeneration is a progressive eye condition that affects central vision, making tasks like reading and recognizing faces difficult. It’s most common in older adults and can be managed through early detection, nutritional support, and treatment.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.